CRNX Fail-to-Deliver

Crinetics Pharmaceuticals, Inc. (CRNX) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $9.01B, listed on NASDAQ, employing roughly 594 people, carrying a beta of 0.13 to the broader market. Crinetics Pharmaceuticals, Inc. Led by R. Scott Struthers, public since 2018-07-18.

Fail-to-deliver (FTD) data from the SEC tracks settlement failures where shares were not delivered within the standard settlement period. Persistent FTDs may indicate naked short selling or settlement issues and are monitored by regulators.

Latest Date

2026-09-02

Latest FTD Quantity

72

Latest Price

$84.95

30-Day Avg FTD

33.1K

30-Day Total FTD

992.8K

Showing 30 days of SEC fail-to-deliver data for Crinetics Pharmaceuticals, Inc..

Learn how fails-to-deliver is reported and how to read the data →